Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Development of an immunodeficient pig model allowing long-term accommodation of artificial human vascular tubes.

Itoh M, Mukae Y, Kitsuka T, Arai K, Nakamura A, Uchihashi K, Toda S, Matsubayashi K, Oyama JI, Node K, Kami D, Gojo S, Morita S, Nishida T, Nakayama K, Kobayashi E.

Nat Commun. 2019 May 21;10(1):2244. doi: 10.1038/s41467-019-10107-1. Erratum in: Nat Commun. 2019 Aug 6;10(1):3625.

2.

The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review.

Kannan RY, Salacinski HJ, Sales K, Butler P, Seifalian AM.

Biomaterials. 2005 May;26(14):1857-75. Review.

PMID:
15576160
3.

Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.

Fukunishi T, Best CA, Sugiura T, Opfermann J, Ong CS, Shinoka T, Breuer CK, Krieger A, Johnson J, Hibino N.

J Thorac Cardiovasc Surg. 2017 Apr;153(4):924-932. doi: 10.1016/j.jtcvs.2016.10.066. Epub 2016 Nov 14.

4.

Bioengineering vascularized tissue constructs using an injectable cell-laden enzymatically crosslinked collagen hydrogel derived from dermal extracellular matrix.

Kuo KC, Lin RZ, Tien HW, Wu PY, Li YC, Melero-Martin JM, Chen YC.

Acta Biomater. 2015 Nov;27:151-166. doi: 10.1016/j.actbio.2015.09.002. Epub 2015 Sep 5.

5.

Development of implantable autologous small-calibre vascular grafts from peripheral blood samples.

Aper T, Teebken OE, Krüger A, Heisterkamp A, Hilfiker A, Haverich A.

Zentralbl Chir. 2013 Apr;138(2):173-9. doi: 10.1055/s-0032-1315112. Epub 2013 Jan 22.

PMID:
23341132
6.

Bioengineering human microvascular networks in immunodeficient mice.

Lin RZ, Melero-Martin JM.

J Vis Exp. 2011 Jul 11;(53):e3065. doi: 10.3791/3065.

7.

A self-renewing, tissue-engineered vascular graft for arterial reconstruction.

Torikai K, Ichikawa H, Hirakawa K, Matsumiya G, Kuratani T, Iwai S, Saito A, Kawaguchi N, Matsuura N, Sawa Y.

J Thorac Cardiovasc Surg. 2008 Jul;136(1):37-45, 45.e1. doi: 10.1016/j.jtcvs.2007.06.039.

8.

Tissue-engineered arterial grafts: long-term results after implantation in a small animal model.

Mirensky TL, Nelson GN, Brennan MP, Roh JD, Hibino N, Yi T, Shinoka T, Breuer CK.

J Pediatr Surg. 2009 Jun;44(6):1127-32; discussion 1132-3. doi: 10.1016/j.jpedsurg.2009.02.035.

PMID:
19524728
9.

Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.

Yang D, Guo T, Nie C, Morris SF.

Ann Plast Surg. 2009 Mar;62(3):297-303. doi: 10.1097/SAP.0b013e318197eb19.

PMID:
19240529
10.

Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering.

Luo J, Qin L, Kural MH, Schwan J, Li X, Bartulos O, Cong XQ, Ren Y, Gui L, Li G, Ellis MW, Li P, Kotton DN, Dardik A, Pober JS, Tellides G, Rolle M, Campbell S, Hawley RJ, Sachs DH, Niklason LE, Qyang Y.

Biomaterials. 2017 Dec;147:116-132. doi: 10.1016/j.biomaterials.2017.09.019. Epub 2017 Sep 19.

11.

Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease.

Dean EW, Udelsman B, Breuer CK.

Yale J Biol Med. 2012 Jun;85(2):229-38. Epub 2012 Jun 25. Review.

12.

Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine.

Nobori S, Samelson-Jones E, Shimizu A, Hisashi Y, Yamamoto S, Kamano C, Teranishi K, Vagefi PA, Nuhn M, Okumi M, Wong B, Houser S, Sachs DH, Yamada K.

Transplantation. 2006 Jan 15;81(1):26-35.

PMID:
16421473
13.

New Regenerative Vascular Grafts for Hemodialysis Access: Evaluation of a Preclinical Animal Model.

Valencia Rivero KT, Jaramillo Escobar J, Galvis Forero SD, Miranda Saldaña MC, López Panqueva RDP, Sandoval Reyes NF, Briceño Triana JC.

J Invest Surg. 2018 Jun;31(3):192-200. doi: 10.1080/08941939.2017.1303100. Epub 2017 Apr 17.

PMID:
28414565
14.

Tissue engineered vascular grafts--preclinical aspects.

Thomas LV, Lekshmi V, Nair PD.

Int J Cardiol. 2013 Aug 20;167(4):1091-100. doi: 10.1016/j.ijcard.2012.09.069. Epub 2012 Oct 3. Review.

PMID:
23040078
15.

Vascular tissue engineering and vascularized 3D tissue regeneration.

Ogawa R, Oki K, Hyakusoku H.

Regen Med. 2007 Sep;2(5):831-7. Review.

PMID:
17907934
16.

Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.

Gessaroli M, Bombardi C, Giunti M, Bacci ML.

J Vasc Surg. 2012 Jan;55(1):192-202. doi: 10.1016/j.jvs.2011.07.076. Epub 2011 Sep 23.

17.

Tissue engineered small-diameter vascular grafts.

Schmedlen RH, Elbjeirami WM, Gobin AS, West JL.

Clin Plast Surg. 2003 Oct;30(4):507-17. Review.

PMID:
14621299
18.

Functional small-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model: preliminary findings.

Nelson GN, Mirensky T, Brennan MP, Roh JD, Yi T, Wang Y, Breuer CK.

Arch Surg. 2008 May;143(5):488-94. doi: 10.1001/archsurg.143.5.488.

19.
20.

Development and evaluation of in vivo tissue engineered blood vessels in a porcine model.

Rothuizen TC, Damanik FFR, Lavrijsen T, Visser MJT, Hamming JF, Lalai RA, Duijs JMGJ, van Zonneveld AJ, Hoefer IE, van Blitterswijk CA, Rabelink TJ, Moroni L, Rotmans JI.

Biomaterials. 2016 Jan;75:82-90. doi: 10.1016/j.biomaterials.2015.10.023. Epub 2015 Oct 22.

PMID:
26491997

Supplemental Content

Support Center